Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half and fiscal year June 20, 2021. For the first half, the company expects net sales of ¥70,000 million, operating income was ¥2,100 million and net income attributable to owners of parent of ¥1,500 million or ¥98.83 per share. For the year ending June 20, 2021, the company expects net sales of ¥145,000 million, operating income was ¥5,000 million and net income attributable to owners of parent of ¥3,500 million or ¥230.61 per share.